シングルセルシーケンス市場：製品、用途、エンドユーザー別-2025-2030年の世界予測

シングルセルシーケンス市場は、2023年に25億2,000万米ドルと評価され、2024年には26億4,000万米ドルに達すると予測され、CAGR 4.87％で成長し、2030年には35億1,000万米ドルになると予測されています。

シングルセルシーケンス（SCS）とは、個々の細胞の遺伝物質を分析するプロセスを指し、細胞の多様性と機能を包括的に理解することを可能にします。この技術は、希少な細胞タイプを同定し、疾病メカニズムを理解し、個別化医療のアプローチを促進するために極めて重要です。SCSの必要性は、腫瘍学、神経学、免疫学、発生生物学に応用され、組織内の異種細胞集団の同定を助けることで強調されます。SCSの最終用途は、バイオテクノロジー企業、学術機関、臨床研究所に及んでいます。シングルセルシーケンスの市場は、シーケンス技術の進歩、コストの低下、精密医療の重視の高まりによって大きな影響を受けています。この市場の成長機会は膨大であり、複雑なデータをより良く扱い解釈するためのマイクロ流体工学と計算生物学の革新が成長の原動力となる可能性があります。また、臨床診断や創薬、特にがん治療におけるSCSの利用拡大にもチャンスが広がっています。しかし、市場成長は、技術セットアップのための初期コストの高さやデータ解析の複雑さといった課題によって制約されています。また、増幅バイアスにつながるインプットRNA量の少なさなどの技術的限界も課題となっています。特に、より効率的で費用対効果の高いシーケンスプラットフォームや、シングルセルデータ用に調整された堅牢なバイオインフォマティクスツールの開発を通じて、イノベーションが事業成長を促進する可能性があります。市場のプレーヤーは、実世界での応用のためにヘルスケアプロバイダーとの提携を思い切って行い、その影響力を拡大することができます。市場は急速な技術進歩と高い競合を特徴としているため、企業は競争力を維持するために、大規模データ管理と解釈の両方に対応する統合ソリューションの開発に注力しなければならないです。最終的には、革新的なソリューションの追求と戦略的コラボレーションが、このダイナミックで進化する市場での成長を育むことができます。

市場力学：急速に進化するシングルセルシーケンス市場の主要市場インサイトを公開

シングルセルシーケンス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患および感染症の流行の増加
  • 製薬・バイオテクノロジー企業の増加
  • 幹細胞研究の成長
• 市場抑制要因
  • シングルセルシーケンスの高コスト
• 市場機会
  • 個別化医療やカスタマイズ医療への需要の高まり
  • シングルセルシーケンスと幹細胞研究の可能性の高まり
• 市場の課題
  • 単一DNA分子の測定が困難

ポーターの5つの力：シングルセルシーケンス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：シングルセルシーケンス市場における外部からの影響の把握

外部マクロ環境要因は、シングルセルシーケンス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析シングルセルシーケンス市場における競合情勢の把握

シングルセルシーケンス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスシングルセルシーケンス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、シングルセルシーケンス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨シングルセルシーケンス市場における成功への道筋を描く

シングルセルシーケンス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患および感染症の蔓延の増加
    • 製薬・バイオテクノロジー企業の増加
    • 幹細胞調査の成長
  • 抑制要因
    • 単一細胞シーケンシングの高コスト
  • 機会
    • パーソナライズされた医療やカスタマイズされた医療に対する継続的な需要
    • 単一細胞シーケンシングと幹細胞調査の潜在能力の高まり
  • 課題
    • 単一DNA分子の測定の難しさ
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 シングルセルシーケンス市場：製品別

• 消耗品
  • アッセイキット
  • ビーズ
  • マイクロプレート
• 機器
  • フローサイトメーター
  • マイクロアレイシステム
  • 次世代シーケンシングシステム
  • ポリメラーゼ連鎖反応

第7章 シングルセルシーケンス市場：用途別

• 免疫学
• 微生物学
• 神経学
• 腫瘍学
• 出生前診断

第8章 シングルセルシーケンス市場：エンドユーザー別

• バイオ医薬品・バイオテクノロジー企業
• 病院、診療所、診断ラボ
• 調査・学術研究所

第9章 南北アメリカのシングルセルシーケンス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のシングルセルシーケンス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのシングルセルシーケンス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 10x Genomics, Inc.
• Agilent Technologies, Inc.
• Becton, Dickinson, and Company
• BGI Genomics Co. Ltd.
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• DNA Electronics Ltd.
• F. Hoffmann-La Roche Ltd.
• Illumina, Inc.
• Merck KGaA
• Mission Bio
• Oxford Nanopore Technologies PLC
• PerkinElmer, Inc.
• Qiagen N.V.
• Standard BioTools Inc.

LIST OF FIGURES

• FIGURE 1. SINGLE CELL SEQUENCING MARKET RESEARCH PROCESS
• FIGURE 2. SINGLE CELL SEQUENCING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. SINGLE CELL SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. SINGLE CELL SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. SINGLE CELL SEQUENCING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. SINGLE CELL SEQUENCING MARKET DYNAMICS
• TABLE 7. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY BEADS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY MICROPLATES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY FLOW CYTOMETER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY MICROARRAY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PRE-NATAL DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY BIOPHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY HOSPITALS, CLINICS, & DIAGNOSTIC LABS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY RESEARCH & ACADEMIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 47. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 48. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. CHINA SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. CHINA SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 74. CHINA SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 75. CHINA SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. CHINA SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. INDIA SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. INDIA SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 79. INDIA SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 80. INDIA SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. INDIA SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 163. ITALY SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 164. ITALY SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 165. ITALY SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 166. ITALY SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. ITALY SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 183. POLAND SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 184. POLAND SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 185. POLAND SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 186. POLAND SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. POLAND SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 188. QATAR SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 189. QATAR SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 190. QATAR SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 191. QATAR SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 192. QATAR SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 238. SINGLE CELL SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 239. SINGLE CELL SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023

The Single Cell Sequencing Market was valued at USD 2.52 billion in 2023, expected to reach USD 2.64 billion in 2024, and is projected to grow at a CAGR of 4.87%, to USD 3.51 billion by 2030.

Single cell sequencing (SCS) refers to the process of analyzing the genetic material of individual cells, allowing for a comprehensive understanding of cellular diversity and function. This technology is crucial for identifying rare cell types, understanding disease mechanisms, and expediting personalized medicine approaches. The necessity of SCS is highlighted in its application across oncology, neurology, immunology, and developmental biology, where it aids in the identification of heterogeneous cell populations within tissues. Its end-use scope spans biotechnology firms, academic institutions, and clinical laboratories. The market for single cell sequencing is significantly influenced by advancements in sequencing technologies, decreasing costs, and an increasing emphasis on precision medicine. Opportunities in this market are vast, with potential growth driven by innovations in microfluidics and computational biology to better handle and interpret complex data. There is also a growing opportunity in expanding the use of SCS in clinical diagnostics and drug discovery, particularly in cancer treatment. However, market growth is constrained by challenges such as high initial costs for technology setup and the complexity involved in data analysis. Technical limitations, like low input RNA amounts leading to amplification bias, also pose challenges. Innovation can propel business growth, particularly through the development of more efficient and cost-effective sequencing platforms and robust bioinformatics tools tailored for single cell data. Market players could venture into partnerships with healthcare providers for real-world applications to broaden their impact. As the market is characterized by rapid technological advances and high competition, companies must focus on developing integrated solutions that address both large-scale data management and interpretation to maintain a competitive edge. Ultimately, the pursuit of innovative solutions and strategic collaborations can nurture growth within this dynamic and evolving market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Single Cell Sequencing Market

The Single Cell Sequencing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of chronic and infectious diseases
  • Rising number of pharmaceutical and biotechnology companies
  • Growth in stem-cell research
• Market Restraints
  • High-cost of single-cell sequencing
• Market Opportunities
  • Ongoing demand for personalized or customized medicine
  • Rising potential of single-cell sequencing and stem cell research
• Market Challenges
  • Difficulty in the measurement of single DNA molecule

Porter's Five Forces: A Strategic Tool for Navigating the Single Cell Sequencing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Single Cell Sequencing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Single Cell Sequencing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Single Cell Sequencing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Single Cell Sequencing Market

A detailed market share analysis in the Single Cell Sequencing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Single Cell Sequencing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Single Cell Sequencing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Single Cell Sequencing Market

A strategic analysis of the Single Cell Sequencing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Single Cell Sequencing Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Agilent Technologies, Inc., Becton, Dickinson, and Company, BGI Genomics Co. Ltd., Bio-Rad Laboratories, Inc., Danaher Corporation, DNA Electronics Ltd., F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA, Mission Bio, Oxford Nanopore Technologies PLC, PerkinElmer, Inc., Qiagen N.V., and Standard BioTools Inc..

Market Segmentation & Coverage

This research report categorizes the Single Cell Sequencing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Consumables and Instruments. The Consumables is further studied across Assay Kits, Beads, and Microplates. The Instruments is further studied across Flow Cytometer, Microarray Systems, Next-Generation Sequencing Systems, and Polymerase Chain Reaction.
• Based on Application, market is studied across Immunology, Microbiology, Neurology, Oncology, and Pre-Natal Diagnosis.
• Based on End-User, market is studied across Biopharmaceutical & Biotech Companies, Hospitals, Clinics, & Diagnostic Labs, and Research & Academic Laboratories.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of chronic and infectious diseases
    • 5.1.1.2. Rising number of pharmaceutical and biotechnology companies
    • 5.1.1.3. Growth in stem-cell research
  • 5.1.2. Restraints
    • 5.1.2.1. High-cost of single-cell sequencing
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing demand for personalized or customized medicine
    • 5.1.3.2. Rising potential of single-cell sequencing and stem cell research
  • 5.1.4. Challenges
    • 5.1.4.1. Difficulty in the measurement of single DNA molecule
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Single Cell Sequencing Market, by Product

• 6.1. Introduction
• 6.2. Consumables
  • 6.2.1. Assay Kits
  • 6.2.2. Beads
  • 6.2.3. Microplates
• 6.3. Instruments
  • 6.3.1. Flow Cytometer
  • 6.3.2. Microarray Systems
  • 6.3.3. Next-Generation Sequencing Systems
  • 6.3.4. Polymerase Chain Reaction

7. Single Cell Sequencing Market, by Application

• 7.1. Introduction
• 7.2. Immunology
• 7.3. Microbiology
• 7.4. Neurology
• 7.5. Oncology
• 7.6. Pre-Natal Diagnosis

8. Single Cell Sequencing Market, by End-User

• 8.1. Introduction
• 8.2. Biopharmaceutical & Biotech Companies
• 8.3. Hospitals, Clinics, & Diagnostic Labs
• 8.4. Research & Academic Laboratories

9. Americas Single Cell Sequencing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Single Cell Sequencing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Single Cell Sequencing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 10x Genomics, Inc.
• 2. Agilent Technologies, Inc.
• 3. Becton, Dickinson, and Company
• 4. BGI Genomics Co. Ltd.
• 5. Bio-Rad Laboratories, Inc.
• 6. Danaher Corporation
• 7. DNA Electronics Ltd.
• 8. F. Hoffmann-La Roche Ltd.
• 9. Illumina, Inc.
• 10. Merck KGaA
• 11. Mission Bio
• 12. Oxford Nanopore Technologies PLC
• 13. PerkinElmer, Inc.
• 14. Qiagen N.V.
• 15. Standard BioTools Inc.